The ROS1 Experts

The ROS1 researchers and clinicians listed on this page are the most familiar with ROS1+ cancers, treatments, and clinical trials. If you have questions about the next step in treating ROS1+ cancer, most of them available for second opinions or physician consults. Some offer remote second opinions (submit your medical records and have a consultation by phone), which are not covered by insurance.

D Ross Camidge, MD, PhD
University of Colorado, Denver, Colorado USA
Remote second opinion available

Jeffrey W. Clark, MD
Massachusetts General Hospital, Boston, Massachusetts, USA

Daniel B. Costa, MD, PhD
Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, USA

Jessica Lin, MD
Massachusetts General Hospital, Boston, Massachusetts, USA

Sai-Hong Ignatius Ou, MD, PhD
University of California, Irvine, California, USA

Gregory J. Riely, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, New York, USA

Ravi Salgia, MD, PhD
City of Hope, Duarte, California, USA

Geoffrey I. Shapiro, MD, PhD
Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Ben Solomon, MBBS, PhD
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

jurgenJürgen Wolf, MD
University Hospital of Cologne, Center for Integrated Oncology Köln Bonn, Köln, Germany

Last updated 16-Oct-2020